Whittier Trust’s MacroGenics MGNX Stock Holding History

Whittier Trust’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-675	Closed	-$2K	–	1717
2022 Q2	$2K	Hold	675	–	–	﹤0.01%	1569
2022 Q1	$6K	Hold	675	–	–	﹤0.01%	1425
2021 Q4	$11K	Buy	+675	New	+$12.7K	﹤0.01%	1304

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Whittier Trust's MGNX Position: Q3 2022 in Review

Whittier Trust sold out of MacroGenics (MGNX) in Q3 2022, closing a stake of 675 shares — an estimated $2K sold.

Whittier Trust first reported a position in MGNX in Q4 2021 and held it in 3 quarters. The position peaked at $11K in Q4 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q3 2022.

Whittier Trust reported no remaining MacroGenics position as of Q3 2022 after selling out during the quarter.
Whittier Trust sold 675 MacroGenics shares in Q3 2022, an estimated $2K.
Whittier Trust first reported a position in MacroGenics in Q4 2021 and held it in 3 quarters.
Whittier Trust's MacroGenics position peaked at $11K in Q4 2021.
135 funds tracked by Wall St. Rank held MacroGenics as of Q3 2022.

Based on Whittier Trust's 13F filing for Q3 2022, filed 21 Oct 2022.